Dr. Jeff Geschwind, a leading authority on tumor metabolism, has shaped the future of liver cancer care with groundbreaking research on glycolysis-targeting therapies. His leadership at Johns Hopkins, Yale, and major medical organizations continues to influence global oncology practices and life-saving treatment innovations. https://www.konsilmed.com/en/doctor/dr-jean-francois-jeff-geschwind-md